Morning Briefing
Summaries of health policy coverage from major news organizations
FDA Considers Dropping Avastin Approval, Approves Five-Day Emergency Contraception Pill
The Food and Drug Administration is considering revoking its approval of a last-ditch breast cancer drug over the debate on "medical spending and effectiveness that flared during the battle over health-care reform," The Washington Post reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
